Prevalence and seroprevalence of low-risk human papillomavirus in Korean women

Min A. Kim, Jin Kyoung Oh, Bo Wook Kim, Doobyung Chay, Dong Choon Park, Seok Mo Kim, Eun Suk Kang, Jae-Hoon Kim, Chi Heum Cho, Hai Rim Shin, Kyung Seo

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Little is known about the prevalence and seroprevalence of low-risk human papillomavirus (HPV) and the risk factors for HPV infection in Korean women. We determined the prevalence of low-risk HPV among 902 women aged 20-59 yr and the seroprevalence of low-risk HPV subtypes 6 and 11 among 1,094 women aged 9-59 yr in the general population. Genital low-risk HPV DNA was assessed by liquid hybridization and polymerase chain reaction. Antibody titers against HPV 6 and 11 were measured by a multiplexed competitive luminex technique. The prevalence of genital low-risk HPV was 4.9%. It reached its highest peak of 10.3% at 20-29 yr of age and a second peak of 3.2% at 50-59 yr of age. The seroprevalence of HPV 6 or 11 was 9.4%. It reached its highest peak of 12.7% at 25-29 yr of age and a second peak of 12.3% at 50-59 yr of age. In multivariable analysis, the number of lifetime sexual partners and past history of sexually transmitted diseases were associated with the seroprevalence but not prevalence of HPV. It is suggested that younger women should receive prophylactic HPV vaccination before they become sexually active and exposed to HPV in their 20s. This study provides baseline data for developing HPV vaccination programs and monitoring vaccine efficacy in Korea.

Original languageEnglish
Pages (from-to)922-928
Number of pages7
JournalJournal of Korean medical science
Volume27
Issue number8
DOIs
Publication statusPublished - 2012 Aug 1

Fingerprint

Seroepidemiologic Studies
Human papillomavirus 11
Human papillomavirus 6
Vaccination
Papillomavirus Infections
Sexual Partners
Korea
Sexually Transmitted Diseases
Vaccines
Polymerase Chain Reaction
Antibodies
DNA

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Kim, M. A., Oh, J. K., Kim, B. W., Chay, D., Park, D. C., Kim, S. M., ... Seo, K. (2012). Prevalence and seroprevalence of low-risk human papillomavirus in Korean women. Journal of Korean medical science, 27(8), 922-928. https://doi.org/10.3346/jkms.2012.27.8.922
Kim, Min A. ; Oh, Jin Kyoung ; Kim, Bo Wook ; Chay, Doobyung ; Park, Dong Choon ; Kim, Seok Mo ; Kang, Eun Suk ; Kim, Jae-Hoon ; Cho, Chi Heum ; Shin, Hai Rim ; Seo, Kyung. / Prevalence and seroprevalence of low-risk human papillomavirus in Korean women. In: Journal of Korean medical science. 2012 ; Vol. 27, No. 8. pp. 922-928.
@article{6b0302c0e11645ecb05a4ee4e15fbb85,
title = "Prevalence and seroprevalence of low-risk human papillomavirus in Korean women",
abstract = "Little is known about the prevalence and seroprevalence of low-risk human papillomavirus (HPV) and the risk factors for HPV infection in Korean women. We determined the prevalence of low-risk HPV among 902 women aged 20-59 yr and the seroprevalence of low-risk HPV subtypes 6 and 11 among 1,094 women aged 9-59 yr in the general population. Genital low-risk HPV DNA was assessed by liquid hybridization and polymerase chain reaction. Antibody titers against HPV 6 and 11 were measured by a multiplexed competitive luminex technique. The prevalence of genital low-risk HPV was 4.9{\%}. It reached its highest peak of 10.3{\%} at 20-29 yr of age and a second peak of 3.2{\%} at 50-59 yr of age. The seroprevalence of HPV 6 or 11 was 9.4{\%}. It reached its highest peak of 12.7{\%} at 25-29 yr of age and a second peak of 12.3{\%} at 50-59 yr of age. In multivariable analysis, the number of lifetime sexual partners and past history of sexually transmitted diseases were associated with the seroprevalence but not prevalence of HPV. It is suggested that younger women should receive prophylactic HPV vaccination before they become sexually active and exposed to HPV in their 20s. This study provides baseline data for developing HPV vaccination programs and monitoring vaccine efficacy in Korea.",
author = "Kim, {Min A.} and Oh, {Jin Kyoung} and Kim, {Bo Wook} and Doobyung Chay and Park, {Dong Choon} and Kim, {Seok Mo} and Kang, {Eun Suk} and Jae-Hoon Kim and Cho, {Chi Heum} and Shin, {Hai Rim} and Kyung Seo",
year = "2012",
month = "8",
day = "1",
doi = "10.3346/jkms.2012.27.8.922",
language = "English",
volume = "27",
pages = "922--928",
journal = "Journal of Korean Medical Science",
issn = "1011-8934",
publisher = "Korean Academy of Medical Science",
number = "8",

}

Kim, MA, Oh, JK, Kim, BW, Chay, D, Park, DC, Kim, SM, Kang, ES, Kim, J-H, Cho, CH, Shin, HR & Seo, K 2012, 'Prevalence and seroprevalence of low-risk human papillomavirus in Korean women', Journal of Korean medical science, vol. 27, no. 8, pp. 922-928. https://doi.org/10.3346/jkms.2012.27.8.922

Prevalence and seroprevalence of low-risk human papillomavirus in Korean women. / Kim, Min A.; Oh, Jin Kyoung; Kim, Bo Wook; Chay, Doobyung; Park, Dong Choon; Kim, Seok Mo; Kang, Eun Suk; Kim, Jae-Hoon; Cho, Chi Heum; Shin, Hai Rim; Seo, Kyung.

In: Journal of Korean medical science, Vol. 27, No. 8, 01.08.2012, p. 922-928.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Prevalence and seroprevalence of low-risk human papillomavirus in Korean women

AU - Kim, Min A.

AU - Oh, Jin Kyoung

AU - Kim, Bo Wook

AU - Chay, Doobyung

AU - Park, Dong Choon

AU - Kim, Seok Mo

AU - Kang, Eun Suk

AU - Kim, Jae-Hoon

AU - Cho, Chi Heum

AU - Shin, Hai Rim

AU - Seo, Kyung

PY - 2012/8/1

Y1 - 2012/8/1

N2 - Little is known about the prevalence and seroprevalence of low-risk human papillomavirus (HPV) and the risk factors for HPV infection in Korean women. We determined the prevalence of low-risk HPV among 902 women aged 20-59 yr and the seroprevalence of low-risk HPV subtypes 6 and 11 among 1,094 women aged 9-59 yr in the general population. Genital low-risk HPV DNA was assessed by liquid hybridization and polymerase chain reaction. Antibody titers against HPV 6 and 11 were measured by a multiplexed competitive luminex technique. The prevalence of genital low-risk HPV was 4.9%. It reached its highest peak of 10.3% at 20-29 yr of age and a second peak of 3.2% at 50-59 yr of age. The seroprevalence of HPV 6 or 11 was 9.4%. It reached its highest peak of 12.7% at 25-29 yr of age and a second peak of 12.3% at 50-59 yr of age. In multivariable analysis, the number of lifetime sexual partners and past history of sexually transmitted diseases were associated with the seroprevalence but not prevalence of HPV. It is suggested that younger women should receive prophylactic HPV vaccination before they become sexually active and exposed to HPV in their 20s. This study provides baseline data for developing HPV vaccination programs and monitoring vaccine efficacy in Korea.

AB - Little is known about the prevalence and seroprevalence of low-risk human papillomavirus (HPV) and the risk factors for HPV infection in Korean women. We determined the prevalence of low-risk HPV among 902 women aged 20-59 yr and the seroprevalence of low-risk HPV subtypes 6 and 11 among 1,094 women aged 9-59 yr in the general population. Genital low-risk HPV DNA was assessed by liquid hybridization and polymerase chain reaction. Antibody titers against HPV 6 and 11 were measured by a multiplexed competitive luminex technique. The prevalence of genital low-risk HPV was 4.9%. It reached its highest peak of 10.3% at 20-29 yr of age and a second peak of 3.2% at 50-59 yr of age. The seroprevalence of HPV 6 or 11 was 9.4%. It reached its highest peak of 12.7% at 25-29 yr of age and a second peak of 12.3% at 50-59 yr of age. In multivariable analysis, the number of lifetime sexual partners and past history of sexually transmitted diseases were associated with the seroprevalence but not prevalence of HPV. It is suggested that younger women should receive prophylactic HPV vaccination before they become sexually active and exposed to HPV in their 20s. This study provides baseline data for developing HPV vaccination programs and monitoring vaccine efficacy in Korea.

UR - http://www.scopus.com/inward/record.url?scp=84866516970&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84866516970&partnerID=8YFLogxK

U2 - 10.3346/jkms.2012.27.8.922

DO - 10.3346/jkms.2012.27.8.922

M3 - Article

VL - 27

SP - 922

EP - 928

JO - Journal of Korean Medical Science

JF - Journal of Korean Medical Science

SN - 1011-8934

IS - 8

ER -